http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6821776-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cb4eabaeb27ae1e9f5d45e9c5790fdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92cb17a9bd74004c957e294105f7d91f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13043
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
filingDate 2000-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad4a6c76e973859f11921db8eb04c783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77198cb140c55e0912ad450bbe28a1d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ae2148e1265c8fcf882d88617f04df3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d98d2193abc04bf669f34ad0db53814e
publicationDate 2004-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6821776-B1
titleOfInvention Reconstituting retroviral vector (recon vector) for targeted gene expression
abstract The present invention relates to a retroviral vector which is especially applicable as a safe gene transfer vehicle for targeted gene therapy. Said retroviral vector comprises one or more promoters inserted in antisense orientation within the 5' LTR region and one or more coding sequences inserted in antisense orientation within the 3' LTR region. Both, the promoter as well as the coding sequence, are additionally inserted in such a way as to ensure that the promoter and the coding sequence become duplicated during the process of reverse transcription in a target cell and thus appear in the 3' as well as in the 5' LTR region of the resulting provirus in a fashion where the promoter is located upstream of the coding sequence allowing it to drive gene expression. This system avoids any leakiness of gene expression in the packaging cells, and allows expression of transferred genes in the target cell without the necessity for external stimuli.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009214496-A1
priorityDate 1998-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8911539-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9607748-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5658775-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9709440-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9628563-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20054941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129329937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395503

Total number of triples: 35.